symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
CBIA,0.0003,0,34782711,2790,0,2.0E-4-0.224,-0.0001,Canopus BioPharma Incorporated,USD,,,,Other OTC,PNK,Shell Companies,,"Canopus BioPharma Incorporated, a pharmaceutical research company, provides pharmaceutical products and assay methods to patients suffering from infectious, cancer, and addiction diseases. It also provides antivirals, radiation protection products, oncology products, bio-barcode assays, camelidae blood products, and neutraceutricals. The company was founded in 1996 as Canopus Corporation and changed its name in 2007. Canopus BioPharma Incorporated is based in Santa Monica, California.",Mr. Patrick T. Prendergast,Financial Services,US,,353-627-8674,233 Wilshire Boulevard,Santa Monica,CA,90401,,0,https://financialmodelingprep.com/image-stock/CBIA.png,1999-12-31,True,False,True,False,False
